Genomic Insights Into Multidrug‐Resistant Foodborne Serratia liquefaciens Strains Carrying mcr-9 and Comparative Genomic Analysis of Novel Biosynthetic Gene Clusters
Open Access
- 1 January 2026
- journal article
- Published by Wiley in International Journal of Food Science
- Vol. 2026 (1) , 5035164
Abstract
Serratia liquefaciens is an opportunistic nosocomial pathogen with a wide range of antibiotic resistance patterns. This study reports the characterization of the first mcr-9 –positive S. liquefaciens strains, 35E‐19E1 and CST‐066, isolated from meat products in Japan. The strains were screened for the presence of β ‐lactamases, plasmid‐mediated mobile colistin resistance ( mcr ) genes, and carbapenemase‐encoding genes using PCR. Antimicrobial susceptibility was tested using the broth microdilution method. The strains exhibited multidrug resistance (MDR) phenotypes to third‐generation cephalosporins, cephamycin, fosfomycin, and other clinically important antimicrobials. Genomic DNA sequencing showed that the genome sizes of CST‐066 and 35E‐19E1 are 5,529,704 and 5,261,506 bps, respectively. mcr-9 was identified on a chromosome within a genetic environment that included the two‐component system qseBC , which plays a key role in the signaling network that triggers colistin resistance in Enterobacterales. Downstream genome analysis revealed a 1695‐bp eptB‐like kdo2‐lipid phosphoethanolamine transferase, which is involved in intrinsic polymyxin resistance mechanisms in Serratia spp. The strain 35E‐19E1 carries five CRISPR‐Cas enzymes that are essential for adaptive immunity in bacteria, allowing defense against invading elements. Functional analysis using subsystem technology revealed that both strains possess subsystem features responsible for invasion and adhesion within the host biomes. Genome mining using antiSMASH and BAGL4 revealed various biosynthetic gene clusters, responsible for secondary metabolite synthesis. Notably, we identified novel gene clusters, mainly nonribosomal peptide synthetases, in both the strains, indicating their potential to produce bioactive compounds. Although the presence of mcr-9 in Serratia may not be of clinical significance because of natural resistance of the strain to polymyxins, we shed light on the genomic characteristics of this MDR pathogen and the potential spread of mcr-9 among other bacterial species. The emergence of mcr-9 in drug‐resistant S. liquefaciens provides significant insights, underscoring the need for increased surveillance of this pathogen.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (JP24KA1005)
This publication has 60 references indexed in Scilit:
- Detection of clinical Serratia marcescens isolates carrying blaKPC-2 in a hospital in ChinaHeliyon, 2024
- Molecular characterization and in-depth genome analysis of Enterobacter sp. S-16Functional & Integrative Genomics, 2023
- Comparative molecular profiling of antimicrobial resistance and phylogenetic characterization of multidrug-resistant Escherichia coli isolated from meat sources in 2009 and 2021 in JapanInternational Journal of Food Microbiology, 2023
- Draft genome of Serratia sp. R1 gives an insight into the antibiotic resistant genes against multiple antibioticsMolecular Biology Reports, 2022
- Molecular genetic characteristics of mcr-9-harbouring Salmonella enterica serotype Typhimurium isolated from raw milkInternational Journal of Antimicrobial Agents, 2021
- Bioremediation of Penicillin G by Serratia sp. R1, and enzymatic study through molecular dockingEnvironmental Nanotechnology, Monitoring & Management, 2019
- Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistanceInternational Journal of Antimicrobial Agents, 2019
- Effects of benzalkonium chloride and ethanol on dual-species biofilms of Serratia liquefaciens S1 and Shewanella putrefaciens S4Food Control, 2017
- Multiplex PCR for detection of acquired carbapenemase genesDiagnostic Microbiology and Infectious Disease, 2011
- A nosocomial epidemic ofSerratia liquefaciens urinary tract infection after cystometryEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984